Alto Neuroscience Stock Alpha and Beta Analysis
| ANRO Stock | 16.59 1.21 6.80% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Alto Neuroscience. It also helps investors analyze the systematic and unsystematic risks associated with investing in Alto Neuroscience over a specified time horizon. Remember, high Alto Neuroscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Alto Neuroscience's market risk premium analysis include:
Beta 6.19 | Alpha 2.5 | Risk 12.02 | Sharpe Ratio 0.17 | Expected Return 2.06 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Alto Neuroscience Backtesting, Alto Neuroscience Valuation, Alto Neuroscience Correlation, Alto Neuroscience Hype Analysis, Alto Neuroscience Volatility, Alto Neuroscience History and analyze Alto Neuroscience Performance. Alto Neuroscience Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Alto Neuroscience market risk premium is the additional return an investor will receive from holding Alto Neuroscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Alto Neuroscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Alto Neuroscience's performance over market.| α | 2.50 | β | 6.19 |
Alto Neuroscience expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Alto Neuroscience's Buy-and-hold return. Our buy-and-hold chart shows how Alto Neuroscience performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Alto Neuroscience Market Price Analysis
Market price analysis indicators help investors to evaluate how Alto Neuroscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alto Neuroscience shares will generate the highest return on investment. By understating and applying Alto Neuroscience stock market price indicators, traders can identify Alto Neuroscience position entry and exit signals to maximize returns.
Alto Neuroscience Return and Market Media
The median price of Alto Neuroscience for the period between Sun, Oct 5, 2025 and Sat, Jan 3, 2026 is 13.36 with a coefficient of variation of 34.74. The daily time series for the period is distributed with a sample standard deviation of 4.35, arithmetic mean of 12.52, and mean deviation of 3.38. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Will Alto Neuroscience Inc. stock go up soon - 2025 Top Gainers High Accuracy Buy Signal Tips - newser.com | 10/27/2025 |
2 | NYSE Content Advisory Pre-Market Update Government Shutdown Nears End After 42 Days | 11/11/2025 |
3 | Baird raises Alto Neuroscience stock price target to 22 on clinical progress - Investing.com | 11/13/2025 |
4 | How Alto Neuroscience Inc. stock expands through international markets - Sell Signal Verified Stock Trade Ideas - newser.com | 11/19/2025 |
5 | Alto Neuroscience 4 Shots At Success In CNS Diseases In 2026 - Seeking Alpha | 11/28/2025 |
6 | Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - Business Wire | 12/03/2025 |
7 | Alto Neuroscience Sets New 1-Year High Heres Why | 12/15/2025 |
8 | Will Alto Neuroscience Inc. stock sustain uptrend momentum - 2025 Winners Losers Daily Stock Trend Watchlist - DonanmHaber | 12/19/2025 |
9 | Alto Neuroscience, Inc. is definitely on the radar of institutional investors who own 33 percent of the company | 12/26/2025 |
10 | Alto Neuroscience Shares Down 6 percent - Whats Next - MarketBeat | 01/02/2026 |
About Alto Neuroscience Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Alto or other stocks. Alpha measures the amount that position in Alto Neuroscience has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Interest Debt Per Share | 0.73 | 0.69 | Revenue Per Share | 0.00739 | 0.006569 |
Alto Neuroscience Investors Sentiment
The influence of Alto Neuroscience's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Alto. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Alto Neuroscience's public news can be used to forecast risks associated with an investment in Alto. The trend in average sentiment can be used to explain how an investor holding Alto can time the market purely based on public headlines and social activities around Alto Neuroscience. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Alto Neuroscience's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Alto Neuroscience's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Alto Neuroscience's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Alto Neuroscience.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Alto Neuroscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Alto Neuroscience's short interest history, or implied volatility extrapolated from Alto Neuroscience options trading.
Build Portfolio with Alto Neuroscience
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Alto Neuroscience Backtesting, Alto Neuroscience Valuation, Alto Neuroscience Correlation, Alto Neuroscience Hype Analysis, Alto Neuroscience Volatility, Alto Neuroscience History and analyze Alto Neuroscience Performance. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Alto Neuroscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.